At the end of the 1980 decade, the first reports about the use of oral and sublingual routes of immunotherapy were published. This article reviews some reports comparing sublingual vs subcutaneous immunotherapy.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Survey on Treatment-Seeking Patterns in Patients With Allergic Rhinitis.
J Rhinol
November 2024
Department of Otorhinolaryngology-Head and Neck Surgery, Chuncheon Sacred Heart Hospital, Hallym University College of Medicine, Chuncheon, Republic of Korea.
Background And Objectives: The medications preferred by patients for allergic rhinitis and their usage remain unclear. This study investigated treatment-seeking behaviors in patients with allergic rhinitis, including medical treatments, environmental controls, and surgical treatments.
Methods: In this study, a cross-sectional survey was conducted by internal medicine, pediatric, or otorhinolaryngology physicians at university hospitals from January 2022 to April 2022.
Exploring Opioid Use Disorder Outcomes by Quantitative Urinalysis: Post Hoc Analysis of a Phase 3 Randomized Clinical Trial.
J Addict Med
December 2024
From Camurus AB, Lund, Sweden (SP, FT); New York State Psychiatric Institute, Columbia University Irving Medical Center, New York, NY (EVN); and Center on Drug and Alcohol Research, University of Kentucky College of Medicine, Lexington, KY (MRL, SLW).
Article Synopsis
- Opioid use disorder (OUD) is a pressing global issue, and while urine drug screenings help monitor treatment responses, they typically provide only yes/no results, complicating comparisons between studies due to varying analytical cutoffs.
- This study analyzed data from a 31-week trial involving 428 participants to compare the efficacy of CAM2038 (subcutaneous buprenorphine) to daily sublingual buprenorphine/naloxone, using quantitative urine drug tests to evaluate different cutoffs for opioid detection.
- Results showed that higher cutoff values led to more pronounced differences in treatment effectiveness favoring CAM2038, suggesting that quantitative urinalysis can offer
Application of Nanoparticles for Immunotherapy of Allergic Rhinitis.
Int J Nanomedicine
November 2024
Laboratory Medicine Center, Allergy Center, Department of Transfusion Medicine, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, 310014, People's Republic of China.
Article Synopsis
- Allergen Immunotherapy (AIT) is currently the only treatment that targets the root cause of allergic rhinitis (AR), with established methods like subcutaneous immunotherapy (SCIT) and sublingual immunotherapy (SLIT) showing positive results but also side effects.
- Innovative approaches using nanoparticles (NPs), which are tiny particles (1-100 nm), are being explored as safer and more effective delivery systems for AIT, potentially enhancing immune modulation and drug concentration.
- The review discusses various types of nanoparticle delivery systems, such as chitosan, exosomes, metal, and viral nanoparticles, while highlighting their advantages and limitations, indicating that more research is needed to confirm their effectiveness in treating AR.
[INSTRUCTIONS ON ALLERGEN IMMUNOTHERAPY FOCUSING ON ALLERGEN IMMUNOTHERAPY FOR BRONCHIAL ASTHMA].
Arerugi
January 2024
Department of Respiratory Medicine and Allergy Center, Saitama Medical University.
Efficacy of subcutaneous specific immunotherapy for allergic rhinitis combined with asthma: a retrospective analysis.
Am J Transl Res
October 2024
Department of Pulmonary and Critical Care Medicine, Renmin Hospital, Hubei University of Medicine Shiyan 442000, Hubei, China.
Objective: To evaluate the efficacy of subcutaneous specific immunotherapy (SCIT) for allergic rhinitis (AR) combined with asthma.
Methods: A retrospective analysis of clinical data from 93 patients with AR combined with asthma admitted to our hospital from January 2022 to January 2023 was conducted. Based on the treatment interventions received, the patients were divided into a control group (n=46, receiving sublingual specific immunotherapy [SLIT]) and an observation group (n=47, receiving SCIT).
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!